DUBLIN--(BUSINESS WIRE)--The "US Dry Age-Related Macular Degeneration Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.
US Dry Age-Related Macular Degeneration Market and Competitive Landscape Highlights - 2019, provides comprehensive insights into Dry Age-Related Macular Degeneration pipeline products, Dry Age-Related Macular Degeneration epidemiology, Dry Age-Related Macular Degeneration market valuations and forecast, Dry Age-Related Macular Degeneration drugs sales and competitive landscape in the US.
The research is classified into seven sections - Dry Age-Related Macular Degeneration treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.
Research Scope
- Dry Age-Related Macular Degeneration pipeline: Find out the products in clinical trials for the treatment of Dry Age-Related Macular Degeneration by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Dry Age-Related Macular Degeneration epidemiology: Find out the number of patients diagnosed (prevalence) with Dry Age-Related Macular Degeneration in the US
- Dry Age-Related Macular Degeneration drugs: Identify key products marketed and prescribed for Dry Age-Related Macular Degeneration in the US, including trade name, molecule name, and company
- Dry Age-Related Macular Degeneration drugs sales: Find out the sales revenues of Dry Age-Related Macular Degeneration drugs in the US
- Dry Age-Related Macular Degeneration market valuations: Find out the market size for Dry Age-Related Macular Degeneration drugs in 2018 in the US. Find out how the market advanced from 2014 and forecast to 2024
- Dry Age-Related Macular Degeneration drugs market share: Find out the market shares for key Dry Age-Related Macular Degeneration drugs in the US
Benefits of this Research
- Support monitoring and reporting national Dry Age-Related Macular Degeneration market analysis and sales trends
- Track competitor drugs sales and market share in the US Dry Age-Related Macular Degeneration market
- Track competitive developments in Dry Age-Related Macular Degeneration market and present key issues and learnings
- Synthesize insights for Dry Age-Related Macular Degeneration market and products to drive business performance
- Answer key business questions about the Dry Age-Related Macular Degeneration market
- Evaluate commercial market opportunity assessment, positioning, and segmentation for Dry Age-Related Macular Degeneration products
- Supports decision making in R&D to long term marketing strategies
Key Topics Covered
1) Dry Age-Related Macular Degeneration Treatments
2) Dry Age-Related Macular Degeneration Pipeline
3) US Dry Age-Related Macular Degeneration Epidemiology
4) Marketed Drugs for Dry Age-Related Macular Degeneration in US
5) US Dry Age-Related Macular Degeneration Market Size and Forecast
6) US Dry Age-Related Macular Degeneration Products Sales and Forecast
7) US Dry Age-Related Macular Degeneration Market Competitive Landscape
8) Methodology
List of Tables
1. Dry Age-Related Macular Degeneration Phase 3 Clinical Trials, 2019
2. Dry Age-Related Macular Degeneration Phase 2 Clinical Trials, 2019
3. Dry Age-Related Macular Degeneration Phase 1 Clinical Trials, 2019
4. Dry Age-Related Macular Degeneration Epidemiology, US, 2014 - 2024
5. Marketed Drugs for Dry Age-Related Macular Degeneration, US, 2018
6. Dry Age-Related Macular Degeneration Market Size and Forecast ($), US, 2014 - 2024
7. Dry Age-Related Macular Degeneration Product Sales ($), US, 2014 - 2024
List of Figures
1. Dry Age-Related Macular Degeneration Epidemiology, US, 2014 - 2024
2. Dry Age-Related Macular Degeneration Market Size and Forecast ($), US, 2014 - 2024
3. Dry Age-Related Macular Degeneration Products Market Share (%), US, 2018
For more information about this report visit https://www.researchandmarkets.com/r/c0grn9
